+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Toxicity Testing Outsourcing Market Size, Share & Industry Trends Analysis Report by End-use, Method, GLP, Regional Outlook and Forecast, 2022-2028

  • PDF Icon

    Report

  • 188 Pages
  • September 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5673596
Description Jump to:
The Global Toxicity Testing Outsourcing Market size is expected to reach $4.9 billion by 2028, rising at a market growth of 8.4% CAGR during the forecast period.



Preclinical testing for a chemical destined for human exposure frequently includes toxicology testing. To establish safe exposure dosages in model organisms, various stages of in silico, in vitro, and in vivo research are carried out. The next stage of research entails first-in-man studies for human toxicological testing, if necessary.

The pharmaceutical business, biotechnology firms, contract research groups, or environmental scientists may all carry out toxicology testing. Testing for toxicity looks at the chemical components of completed items such as pesticides, drugs, cosmetics, food additives like packing materials, artificial sweeteners, and air fresheners. A variety of techniques are used to evaluate the compounds, including cutaneous application, respiration, oral intake, injection, and aquatic environments.

They can be rubbed on the skin or eyes, injected intramuscularly, intravenously, or subcutaneously or inhaled by covering the animals with a mask or putting them in a respiration chamber. They can also be given orally by mixing them into the animals' food or inserting a tube into their stomachs. Testing for toxicity can also be done on substances that need to be discarded, like silt that needs to be dumped in a marine environment.

COVID-19 Impact Analysis

Companies have, however, adopted a number of techniques, such as varying shifts, downsizing staff, and working remotely, to lessen or eliminate these issues. Numerous businesses provided innovative testing and solutions to aid the government's attempts to halt the COVID-19 outbreak. These companies were able to lessen the impact COVID-19 has on their daily operations. The reduced working of these laboratories necessitated the need for outsourcing testing and research. Therefore, COVID-19 propelled the trend of outsourcing and as such had a positive impact on the toxicity testing outsourcing market.

Market Growth Factors

Acceptance Of Outsourcing Toxicity Tests Among Animal Care Societies

For the sale and importation of some consumer goods, genetically modified eatables, medical devices, vaccines, pharmaceuticals, and industrial chemicals, and pesticides, government rules in a number of nations demand genotoxicity testing on animals. Millions of animals are used every year for drug discovery, including monkeys, birds, hamsters, guinea pigs, frogs, cats, and mice. As a result, numerous animal ethical independent committees have been established in numerous countries all over the world.

Increased Efficiency In Drug Discovery And Personalized Therapy

Strategies to establish or predict safety and effectiveness in humans prior to drugs entering clinical trials could significantly lower the failure rate of novel therapeutics. More focus has been placed on in vitro drug discovery and personalized treatments. Additionally, there is a growing demand for humanistic animal models, which will most likely open up a variety of opportunities for rivals in gene toxicology research in the near future. Predetermining the toxicity of intended drugs could help in mitigating the negative effects.

Market Restraining Factors

Scarcity Of Skilled Professionals And Reluctance Of Regulatory Bodies

In vitro toxicity assessment methodologies are being used more often across a range of sectors. Regulatory agencies may substitute validated alternative testing for in vivo tests. Several nations have expressed a reluctance to adopt in vitro testing instead of in vivo procedures, even though the assay has proven its greater scientific relevance. In the United States, a number of regulatory agencies continue to use data derived from animal testing. Many organizations use in vivo approaches to evaluate novel toxicological test methods.

Method Outlook

Based on method, the toxicity testing outsourcing market is categorized into in vitro and in vivo. The in vivo segment garnered a significant revenue share in the toxicity resting outsourcing market in 2021. An essential component of medical research generally is in vivo testing, particularly in clinical trials. Studies conducted in living organisms (in vivo) offer useful knowledge about a substance's effects or the progression of a disease.



GLP Type Outlook

On the basis of GLP type, the toxicity testing outsourcing market is bifurcated into GLP and non-GLP. The GLP (Good Laboratory Practices) segment procured the largest revenue share in the toxicity testing outsourcing market in 2021. For safe exposure to people, clinical studies such as safety pharmacology, genotoxicity, and repeated dosage toxicity must be conducted in accordance with GLP guidelines. These research projects must be finished before submitting an IND application.

End-Use Outlook

Based on end-use, the toxicity testing outsourcing market is divided into pharmaceutical & biopharmaceutical companies, academic & research institutes, and others. The pharmaceutical & biopharmaceutical companies segment recorded the maximum revenue share in the toxicity testing outsourcing market in 2021. This is because small and midsize pharmaceutical businesses, that lack experience in the preclinical phase of toxicity testing of drug development, are increasingly outsourcing end-to-end services.

Regional Outlook

On the basis of region, the toxicity testing outsourcing market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North American region witnessed the highest revenue share in the toxicity testing outsourcing market in 2021. The availability of enough infrastructure to enable the development and growth of drug discovery technologies, an increase in medical spending, and an intense emphasis on drug development by governmental agencies are all contributing factors.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific Group, WuXi AppTec Co., Ltd., SGS S.A., Intertek Group PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., ICON PLC, and Medpace Holdings, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End Use

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic & Research Institutes
  • Others

By Method

  • In Vitro
  • In Vivo

By GLP

  • GLP
  • Non-GLP

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific Group
  • WuXi AppTec Co., Ltd.
  • SGS S.A.
  • Intertek Group PLC
  • Catalent, Inc.
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Medpace Holdings, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Toxicity Testing Outsourcing Market, by End Use
1.4.2 Global Toxicity Testing Outsourcing Market, by Method
1.4.3 Global Toxicity Testing Outsourcing Market, by GLP
1.4.4 Global Toxicity Testing Outsourcing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Toxicity Testing Outsourcing Market by End Use
3.1 Global Pharmaceutical & Biopharmaceutical Companies Market by Region
3.2 Global Academic & Research Institutes Market by Region
3.3 Global Others Market by Region
Chapter 4. Global Toxicity Testing Outsourcing Market by Method
4.1 Global In Vitro Market by Region
4.2 Global In Vivo Market by Region
Chapter 5. Global Toxicity Testing Outsourcing Market by GLP
5.1 Global GLP Market by Region
5.2 Global Non-GLP Market by Region
Chapter 6. Global Toxicity Testing Outsourcing Market by Region
6.1 North America Toxicity Testing Outsourcing Market
6.1.1 North America Toxicity Testing Outsourcing Market by End Use
6.1.1.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
6.1.1.2 North America Academic & Research Institutes Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Toxicity Testing Outsourcing Market by Method
6.1.2.1 North America In Vitro Market by Country
6.1.2.2 North America In Vivo Market by Country
6.1.3 North America Toxicity Testing Outsourcing Market by GLP
6.1.3.1 North America GLP Market by Country
6.1.3.2 North America Non-GLP Market by Country
6.1.4 North America Toxicity Testing Outsourcing Market by Country
6.1.4.1 US Toxicity Testing Outsourcing Market
6.1.4.1.1 US Toxicity Testing Outsourcing Market by End Use
6.1.4.1.2 US Toxicity Testing Outsourcing Market by Method
6.1.4.1.3 US Toxicity Testing Outsourcing Market by GLP
6.1.4.2 Canada Toxicity Testing Outsourcing Market
6.1.4.2.1 Canada Toxicity Testing Outsourcing Market by End Use
6.1.4.2.2 Canada Toxicity Testing Outsourcing Market by Method
6.1.4.2.3 Canada Toxicity Testing Outsourcing Market by GLP
6.1.4.3 Mexico Toxicity Testing Outsourcing Market
6.1.4.3.1 Mexico Toxicity Testing Outsourcing Market by End Use
6.1.4.3.2 Mexico Toxicity Testing Outsourcing Market by Method
6.1.4.3.3 Mexico Toxicity Testing Outsourcing Market by GLP
6.1.4.4 Rest of North America Toxicity Testing Outsourcing Market
6.1.4.4.1 Rest of North America Toxicity Testing Outsourcing Market by End Use
6.1.4.4.2 Rest of North America Toxicity Testing Outsourcing Market by Method
6.1.4.4.3 Rest of North America Toxicity Testing Outsourcing Market by GLP
6.2 Europe Toxicity Testing Outsourcing Market
6.2.1 Europe Toxicity Testing Outsourcing Market by End Use
6.2.1.1 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
6.2.1.2 Europe Academic & Research Institutes Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Toxicity Testing Outsourcing Market by Method
6.2.2.1 Europe In Vitro Market by Country
6.2.2.2 Europe In Vivo Market by Country
6.2.3 Europe Toxicity Testing Outsourcing Market by GLP
6.2.3.1 Europe GLP Market by Country
6.2.3.2 Europe Non-GLP Market by Country
6.2.4 Europe Toxicity Testing Outsourcing Market by Country
6.2.4.1 Germany Toxicity Testing Outsourcing Market
6.2.4.1.1 Germany Toxicity Testing Outsourcing Market by End Use
6.2.4.1.2 Germany Toxicity Testing Outsourcing Market by Method
6.2.4.1.3 Germany Toxicity Testing Outsourcing Market by GLP
6.2.4.2 UK Toxicity Testing Outsourcing Market
6.2.4.2.1 UK Toxicity Testing Outsourcing Market by End Use
6.2.4.2.2 UK Toxicity Testing Outsourcing Market by Method
6.2.4.2.3 UK Toxicity Testing Outsourcing Market by GLP
6.2.4.3 France Toxicity Testing Outsourcing Market
6.2.4.3.1 France Toxicity Testing Outsourcing Market by End Use
6.2.4.3.2 France Toxicity Testing Outsourcing Market by Method
6.2.4.3.3 France Toxicity Testing Outsourcing Market by GLP
6.2.4.4 Russia Toxicity Testing Outsourcing Market
6.2.4.4.1 Russia Toxicity Testing Outsourcing Market by End Use
6.2.4.4.2 Russia Toxicity Testing Outsourcing Market by Method
6.2.4.4.3 Russia Toxicity Testing Outsourcing Market by GLP
6.2.4.5 Spain Toxicity Testing Outsourcing Market
6.2.4.5.1 Spain Toxicity Testing Outsourcing Market by End Use
6.2.4.5.2 Spain Toxicity Testing Outsourcing Market by Method
6.2.4.5.3 Spain Toxicity Testing Outsourcing Market by GLP
6.2.4.6 Italy Toxicity Testing Outsourcing Market
6.2.4.6.1 Italy Toxicity Testing Outsourcing Market by End Use
6.2.4.6.2 Italy Toxicity Testing Outsourcing Market by Method
6.2.4.6.3 Italy Toxicity Testing Outsourcing Market by GLP
6.2.4.7 Rest of Europe Toxicity Testing Outsourcing Market
6.2.4.7.1 Rest of Europe Toxicity Testing Outsourcing Market by End Use
6.2.4.7.2 Rest of Europe Toxicity Testing Outsourcing Market by Method
6.2.4.7.3 Rest of Europe Toxicity Testing Outsourcing Market by GLP
6.3 Asia Pacific Toxicity Testing Outsourcing Market
6.3.1 Asia Pacific Toxicity Testing Outsourcing Market by End Use
6.3.1.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country
6.3.1.2 Asia Pacific Academic & Research Institutes Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Toxicity Testing Outsourcing Market by Method
6.3.2.1 Asia Pacific In Vitro Market by Country
6.3.2.2 Asia Pacific In Vivo Market by Country
6.3.3 Asia Pacific Toxicity Testing Outsourcing Market by GLP
6.3.3.1 Asia Pacific GLP Market by Country
6.3.3.2 Asia Pacific Non-GLP Market by Country
6.3.4 Asia Pacific Toxicity Testing Outsourcing Market by Country
6.3.4.1 China Toxicity Testing Outsourcing Market
6.3.4.1.1 China Toxicity Testing Outsourcing Market by End Use
6.3.4.1.2 China Toxicity Testing Outsourcing Market by Method
6.3.4.1.3 China Toxicity Testing Outsourcing Market by GLP
6.3.4.2 Japan Toxicity Testing Outsourcing Market
6.3.4.2.1 Japan Toxicity Testing Outsourcing Market by End Use
6.3.4.2.2 Japan Toxicity Testing Outsourcing Market by Method
6.3.4.2.3 Japan Toxicity Testing Outsourcing Market by GLP
6.3.4.3 India Toxicity Testing Outsourcing Market
6.3.4.3.1 India Toxicity Testing Outsourcing Market by End Use
6.3.4.3.2 India Toxicity Testing Outsourcing Market by Method
6.3.4.3.3 India Toxicity Testing Outsourcing Market by GLP
6.3.4.4 South Korea Toxicity Testing Outsourcing Market
6.3.4.4.1 South Korea Toxicity Testing Outsourcing Market by End Use
6.3.4.4.2 South Korea Toxicity Testing Outsourcing Market by Method
6.3.4.4.3 South Korea Toxicity Testing Outsourcing Market by GLP
6.3.4.5 Singapore Toxicity Testing Outsourcing Market
6.3.4.5.1 Singapore Toxicity Testing Outsourcing Market by End Use
6.3.4.5.2 Singapore Toxicity Testing Outsourcing Market by Method
6.3.4.5.3 Singapore Toxicity Testing Outsourcing Market by GLP
6.3.4.6 Malaysia Toxicity Testing Outsourcing Market
6.3.4.6.1 Malaysia Toxicity Testing Outsourcing Market by End Use
6.3.4.6.2 Malaysia Toxicity Testing Outsourcing Market by Method
6.3.4.6.3 Malaysia Toxicity Testing Outsourcing Market by GLP
6.3.4.7 Rest of Asia Pacific Toxicity Testing Outsourcing Market
6.3.4.7.1 Rest of Asia Pacific Toxicity Testing Outsourcing Market by End Use
6.3.4.7.2 Rest of Asia Pacific Toxicity Testing Outsourcing Market by Method
6.3.4.7.3 Rest of Asia Pacific Toxicity Testing Outsourcing Market by GLP
6.4 LAMEA Toxicity Testing Outsourcing Market
6.4.1 LAMEA Toxicity Testing Outsourcing Market by End Use
6.4.1.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
6.4.1.2 LAMEA Academic & Research Institutes Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Toxicity Testing Outsourcing Market by Method
6.4.2.1 LAMEA In Vitro Market by Country
6.4.2.2 LAMEA In Vivo Market by Country
6.4.3 LAMEA Toxicity Testing Outsourcing Market by GLP
6.4.3.1 LAMEA GLP Market by Country
6.4.3.2 LAMEA Non-GLP Market by Country
6.4.4 LAMEA Toxicity Testing Outsourcing Market by Country
6.4.4.1 Brazil Toxicity Testing Outsourcing Market
6.4.4.1.1 Brazil Toxicity Testing Outsourcing Market by End Use
6.4.4.1.2 Brazil Toxicity Testing Outsourcing Market by Method
6.4.4.1.3 Brazil Toxicity Testing Outsourcing Market by GLP
6.4.4.2 Argentina Toxicity Testing Outsourcing Market
6.4.4.2.1 Argentina Toxicity Testing Outsourcing Market by End Use
6.4.4.2.2 Argentina Toxicity Testing Outsourcing Market by Method
6.4.4.2.3 Argentina Toxicity Testing Outsourcing Market by GLP
6.4.4.3 UAE Toxicity Testing Outsourcing Market
6.4.4.3.1 UAE Toxicity Testing Outsourcing Market by End Use
6.4.4.3.2 UAE Toxicity Testing Outsourcing Market by Method
6.4.4.3.3 UAE Toxicity Testing Outsourcing Market by GLP
6.4.4.4 Saudi Arabia Toxicity Testing Outsourcing Market
6.4.4.4.1 Saudi Arabia Toxicity Testing Outsourcing Market by End Use
6.4.4.4.2 Saudi Arabia Toxicity Testing Outsourcing Market by Method
6.4.4.4.3 Saudi Arabia Toxicity Testing Outsourcing Market by GLP
6.4.4.5 South Africa Toxicity Testing Outsourcing Market
6.4.4.5.1 South Africa Toxicity Testing Outsourcing Market by End Use
6.4.4.5.2 South Africa Toxicity Testing Outsourcing Market by Method
6.4.4.5.3 South Africa Toxicity Testing Outsourcing Market by GLP
6.4.4.6 Nigeria Toxicity Testing Outsourcing Market
6.4.4.6.1 Nigeria Toxicity Testing Outsourcing Market by End Use
6.4.4.6.2 Nigeria Toxicity Testing Outsourcing Market by Method
6.4.4.6.3 Nigeria Toxicity Testing Outsourcing Market by GLP
6.4.4.7 Rest of LAMEA Toxicity Testing Outsourcing Market
6.4.4.7.1 Rest of LAMEA Toxicity Testing Outsourcing Market by End Use
6.4.4.7.2 Rest of LAMEA Toxicity Testing Outsourcing Market by Method
6.4.4.7.3 Rest of LAMEA Toxicity Testing Outsourcing Market by GLP
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Eurofins Scientific Group
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Acquisition and Mergers:
7.3 Charles River Laboratories International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Acquisition and Mergers:
7.4 WuXi AppTec Co., Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.5 SGS S.A.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.6 Intertek Group PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 Catalent, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expenses
7.8 Laboratory Corporation of America Holdings
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.9 ICON PLC
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.10. Medpace Holdings, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific Group
  • WuXi AppTec Co., Ltd.
  • SGS S.A.
  • Intertek Group PLC
  • Catalent, Inc.
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Medpace Holdings, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Toxicity Testing Outsourcing Market Size, Share & Trends Analysis Report by Method (In Vitro, In Vivo), GLP (GLP, Non GLP), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Toxicity Testing Outsourcing Market Size, Share & Trends Analysis Report by Method (In Vitro, In Vivo), GLP (GLP, Non GLP), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Toxicity Testing Outsourcing Market by Method, Practice Type, End-Use - Global Forecast 2025-2030 - Product Image

Toxicity Testing Outsourcing Market by Method, Practice Type, End-Use - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Healthcare Testing, Inspection, & Certification Outsourcing Market by Product, Type, End-use - Global Forecast 2025-2030 - Product Image

Healthcare Testing, Inspection, & Certification Outsourcing Market by Product, Type, End-use - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Regulatory Affairs Outsourcing Global Market Report 2024 - Product Image

Regulatory Affairs Outsourcing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Regulatory Affairs Outsourcing - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Regulatory Affairs Outsourcing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.